Epilepsy Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have epilepsy that has not been controlled by medication
- People who are 18 years of age or older
- People who experience at least 2 seizures per month on average
- People who have kept a detailed seizure diary for at least 3 months
Who may not be able to join:
- People who have an implanted brain stimulation device (such as deep brain stimulation or responsive neurostimulation)
- People who have a shunt placed inside the skull
- People whose skin is sensitive to light
- People who have cancer on their scalp
- People who are taking any medication that is known to cause sensitivity to light
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Daniel Goldenholz, MD PhD, Beth Israel Deaconess Medical Center
Phone: 617-632-8930
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
seizure rate reduction; tolerability of daily photobiomodulation
Can't join this trial?
Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.